Prevalence of human papillomavirus infection of 65,613 women in East China

[1] Zur Hausen H(1988)Papillomaviruses in human cancers Mol Carcinog 1 147-150

[2] Burchell AN(2006)Epidemiology and transmission daynamics of genital HPV infection Vaccine 24 S52-S61

[3] Winer RL(2003)Epidemiologic classification of human papillomavirus types associated with cervical cancer N Engl J Med 348 518-527

[4] De Sanjosé S(2006)Genital human papillomavirus infection Clin Infect Dis 43 624-629

[5] Muñoz N(2009)A review of human carcinogens-part B: biological agents Lancet Oncol. 10 321-322

[6] Bosch FX(2005)Carcinogenicity of human papillomaviruses Lancet Oncol. 6 204-459

[7] De Sanjosé S(2007)Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a metal-analysis Lancet Infect Dis 7 453-211

[8] Dunne EF(1999)Human papillomavirus in malignant cervical lesions in Surinam, a high-risk country, compared to the Netherlands, a low-risk country Int J Gynecol Cancer 9 206-4162

[9] Markwitz LE(2006)Simultaneous amplification and identification of 25 huamn papillomavirus types with Templex technology J Clin Microbiol 44 4157-578

[10] Bouvard V(2010)An analysis on the combination expression of HPV L1 capsid protein and p16INK4a in cervical lesions Diagn Cytopathol 38 573-2664

[1] Zur Hausen H(1988)Papillomaviruses in human cancers Mol Carcinog 1 147-150

[2] Burchell AN(2006)Epidemiology and transmission daynamics of genital HPV infection Vaccine 24 S52-S61

[3] Winer RL(2003)Epidemiologic classification of human papillomavirus types associated with cervical cancer N Engl J Med 348 518-527

[4] De Sanjosé S(2006)Genital human papillomavirus infection Clin Infect Dis 43 624-629

[5] Muñoz N(2009)A review of human carcinogens-part B: biological agents Lancet Oncol. 10 321-322

[6] Bosch FX(2005)Carcinogenicity of human papillomaviruses Lancet Oncol. 6 204-459

[7] De Sanjosé S(2007)Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a metal-analysis Lancet Infect Dis 7 453-211

[8] Dunne EF(1999)Human papillomavirus in malignant cervical lesions in Surinam, a high-risk country, compared to the Netherlands, a low-risk country Int J Gynecol Cancer 9 206-4162

[9] Markwitz LE(2006)Simultaneous amplification and identification of 25 huamn papillomavirus types with Templex technology J Clin Microbiol 44 4157-578

[10] Bouvard V(2010)An analysis on the combination expression of HPV L1 capsid protein and p16INK4a in cervical lesions Diagn Cytopathol 38 573-2664